The metabolism of 16-fluoroestradiols in vivo: Chemical strategies for restricting the oxidative biotransformations of an estrogen-receptor imaging agent

Steroids

Volumn 62, Issue 12, 1997, Pages 750-761

  Stalford, Anne C ^a   Maggs, James L ^a   Gilchrist, Thomas L ^a   Park, B Kevin ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

16 fluoroestrogen; Catecholestrogen; Estrogen; Metabolism

Indexed keywords

ESTRADIOL DERIVATIVE; ESTROGEN RECEPTOR; ESTRONE DERIVATIVE; RADIOPHARMACEUTICAL AGENT; TRITIUM;

ANIMAL EXPERIMENT; ARTICLE; DRUG METABOLISM; DRUG OXIDATION; DRUG SYNTHESIS; DRUG TRANSFORMATION; DRUG TRANSPORT; MALE; NONHUMAN; RAT;

ANIMALS; BIOTRANSFORMATION; ESTRADIOL; GLUCURONATES; ISOMERISM; MALE; MASS SPECTROMETRY; OXIDATION-REDUCTION; RATS; RATS, WISTAR; STRUCTURE-ACTIVITY RELATIONSHIP; TRITIUM;

EID: 0031450926     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(97)00116-5     Document Type: Article

References (50)

1. Pomper MG, Van Brocklin H, Thieme AM, Thomas RD. Kiesewetter DO, Carlson KE, Mathias CJ, Welch MJ, Katzenellenbogen JA (1990). 11β-Methoxy-, 11β-ethyl-and 17α-ethynyl-substituted 16α-fluoroestradiols: Receptor-based imaging agents with enhanced uptake efficiency and selectivity. J Med Chem 33:3143-3155.
2. 18F]fluoro-11β-methoxyestradiol: Control of metabolism enhances target tissue uptake. J Nucl Med 32: 974-975.
3. 18F]fluoroestradiols: Selective receptor-based PET imaging agents. Nucl Med Biol 19:363-374.
4. 18F]Fluoromoxestrol: A potent, metabolically stable positron emission tomography imaging agent for estrogen receptor positive human breast tumors. Life Sci 53:811-819.
5. Cummins CH (1993). Radiolabeled steroidal estrogens in cancer research. Steroids 58:245-259.
6. Kiesewetter DO, Kilbourn MR, Landvatter SW, Heiman DF, Katzenellenbogen JA, Welch MJ (1984). Preparation of four fluorine-18-labeled estrogens and their selective uptakes in target tissues of immature rats. J Nucl Med 25:1212-1221.
7. Mintun MA, Welch MJ, Siegel BA, Mathias CJ, Brodack JW, McGuire AH, Katzenellenbogen JA (1988). Breast cancer: PET imaging of estrogen receptors. Radiology 169:45-48.
8. 18F]fluoro-17β-estradiol uptake in metastatic breast carcinoma. J Nucl Med 32:1526-1531.
9. Dehdashti F, Mortimer JE, Siegel BA, Griffeth LK, Bonasera TF, Fusselman MJ, Detert DD, Cutler PD, Kalzenellenbogen JA, Welch MJ (1995). Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays. J Nucl Med 36:1766-1774.
10. Katzenellenbogen JA (1992). The pharmacology of steroid radio-pharmaceuticals: Specific and non-specific binding and uptake selectivity. In: Nunn AD (ed), Radiopharmaceuticals: Chemistry and Pharmacology. Marcel Dekker, New York, pp. 297-331.
11. Gantchev TG, Ali H, van Lier JE (1994). Quantitative structure-activity relationships/comparative molecular field analysis (QSAR/CoMFA) for receptor-binding properties of halogenated estradiol derivatives. J Med Chem 37:4164-4176.
12. 3H]17β-oestradiol in rats: Male-specific 15α-and male-selective 16α-hydroxylation and female-selective catechol formation. J Steroid Biochem Mol Biol 42:65-76.
13. Morgan P, Maggs JL, Bulman-Page PC, Hussain F. Park BK (1992). The metabolism of 2-and 4-fluoro-17β-oestradiol in the rat and its implications for oestrogen carcinogenesis Biochem Pharmacol 43: 985-994.
14. Stalford AC, Maggs JL, Gilchrist TL. Park BK (1994). Catecholestrogens as mediators of carcinogenesis: Correlation of aromatic hydroxylation of estradiol and its fluorinated analogs with tumor induction in syrian hamsters. Mol Pharmacol 45:1259-1267.
15. Bonham NM, Maggs JL, Bulman-Page PC. Park BK (1994). Structure-metabolism relationships of ring-A halogenated analogues of 17α-ethynyloestradiol. J Steroid Biochem Mol Biol 49:203-211.
16. Morgan P, Maggs JL, Page PCB, Park BK (1992). Oxidative dehalogenation of 2-fluoro-17α-ethynyloestradiol in vivo: A distal structure-metabolism relationship of 17α-ethynylation. Biochem Pharmacol 44:1717-1724.
17. Nambara T, Bae YH, Nakubo M (1971). Analytical chemical studies on steroids. Part L. Determination of urinary metabolites of 16α-chloroestrone methyl ether by gas chromatography. J Chromatogr 60:418-421.
18. Nambara T, Nokubo M, Bae YH (1971). Analytical chemical studies on steroids XLVIII. Isolation and characterization of urinary metabolites of 16α-chloroestrone methyl ether in the rabbit. Chem Pharm Bull 19:2096-2101.
19. Abel SM, Back DJ, Maggs JL, Park BK (1993). Cortisol metabolism by human liver in vitro - IV. Metabolism of 9α-fluorocortisol by human liver microsomes and cytosol. J Steroid Biochem Mol Biol 46:833-838.
20. Umemoto T, Tomita K, Kawada K (1990). N-Fluoropyridinium triflate: An electrophilic fluorinating agent. Org Synth 69:129-143.
21. Kiesewetter DO, Katzenellenbogen JA, Kilbourn MR, Welch MJ (1984). Synthesis of 16-fluoroestrogens by unusually facile fluoride ion displacement reactions: Prospects for the preparation of fluorine-18 labeled estrogens. J Org Chem 49:4900-4905.
22. Maggs JL, Grabowski PS, Park BK (1983). Protection of catechol oestrogen from oxidation during enzymic hydrolysis of biliary conjugates. J Steroid Biochem 19:1235-1237.
23. Slikker W, Lipe GW, Newport GD (1981). High-performance liquid chromatographic analysis of estradiol-17β and metabolites in biological media. J Chromatogr 224:205-219.
24. Patrick TB, Mortezania R (1988). Synthesis of 16α-and 16β-fluoro-17β-estradiol by fluorination of estrone enols. J Org Chem 53: 5153-5155.
25. Umemoto T, Fukami S, Tomizawa G, Harasawa K, Kawada K, Tomita K (1990). Power and structure-variable fluorinating agents. The N-fluoropyridiniurn salt system. J Am Chem Soc 112:8563-8575.
26. Poss AJ, Van Der Puy M, Nalewajek D, Shia GA, Wagner WJ, Frenette RL (1991). N-Fluoropyridinium pyridine heptafluorodiborate: A useful fluorinating agent. J Org Chem 56:5962-5964.
27. McOmie JFW, Watts ML, West DE (1968). Demethylation of aryl methyl ethers by boron tribromide. Tetrahedron 24:2289-2292.
28. Pelletier JD, Labrie F, Poirier D (1994). N-butyl, N-methyl, 11-[3′, 17′ β-(dihydroxy)-1′ ,3′ ,5′ (10′)-estratrien-16′ α-yl]-9(R/S)-bromoundecanamide: Synthesis and 17β-HSD inhibiting, estrogenic and antiestrogenic activities. Steroids 59:536-547.
29. Page PCB, Hussain F, Maggs JL, Morgan P, Park BK (1990). Efficient regioselective A-ring functionalization of oestrogens. Tetrahedron 46:2059-2068.
30. Krishnamurthy S, Brown HC (1976). Lithium trisiamylborohydride. A new sterically hindered reagent for the reduction of cyclic ketones with exceptional stereoselectivity. J Am Chem Soc 98:3383-3384.
31. Maggs JL, Grabowski PS, Park BK (1983). Drug-protein conjugates-V: Sex-linked differences in the metabolism and irreversible binding of 17α-ethinyestradiol in the rat. Biochem Pharmacol 32: 2793-2800.
32. Poon GK, Chui YC, Jarman M, Rowlands MG, Kokkonen PS, Niessen WMA, Van Der Greef J (1992). Investigation of conjugated metabolites of 4-hydroxyandrost-4-ene-3,17-dione in patient urine by liquid chromatography-atmospheric pressure ionization mass spectrometry. Drug Metab Dispos 20:941-947.
33. Madden S. Maggs JL, Park BK (1996). Bioactivation of carbamazepine in the rat in vivo: evidence for the formation of reactive arene oxide(s). Drug Metab Dispos 24:469-479.
34. Williams KIH (1970). Species difference in the structure of urinary 2-hydroxyestrone "glucuronide." Steroids 15:105-111.
35. Ohkubo T, Takahashi A, Nambara T (1990). Multiplicity of in vitro glucuronidation of 2-hydroxyestriol. J Steroid Biochem 36:501-503.
36. Fishman J (1983). Aromatic hydroxylation of estrogens. Annu Rev Physiol 45:61-72.
37. French AN, Napolitano E, Van Brocklin HF, Brodack JW, Hanson RN, Welch MJ, Katzenellenbogen JA (1991). The β-heteroatom effect in metabolic defluorination: The interaction of resonance and inductive effects may be a fundamental determinant in the metabolic lability of fluorine-substituted compounds. J Label Compound Radiopharm 30:431-133.
38. Teitelbaum PJ, Chu NI, Cho D, Tokes L, Patterson JW, Wagner PJ, Chaplin MD (1981). Mechanism for the oxidative defluorination of flunisolide. J Pharmacol Exp Ther 218:16-22.
39. Heiman DF, Senderoff SG, Katzenellenbogen JA, Neeley RJ (1980). Estrogen receptor based imaging agents. I. synthesis and receptor binding affinity of some aromatic and D-ring halogenated estrogens. J Med Chem 23:994-1002.
40. 131I]iodo-oestradiol and evaluation of its use as a radiotracer for oestrogen receptor positive breast tumours. J Steroid Biochem 22:155-160.
41. Bush IE, Meigs RA, Hunter S (1962). The effect of alkyl and halogen substituents on the oxidation-reduction of 11-oxygen functions of steroids. J Endocrinol 24:ii-iii.
42. Bush IE, Mahesh VB (1964). Metabolism of 11-oxygenated steroids. 3. Some 1-dehydro and 9α-fluoro steroids. Biochem J 93: 236-255.
43. Hanson RN (1992). The influence of structure modification on the metabolic transformations of radiolabeled estrogen derivatives. In: Nunn AD (ed). Radiopharmaceuticals: Chemistry and Pharmacology. Marcel Dekker, New York, pp. 333-364.
44. Bucala R, Ulrich PC, Chait BT, Benscath FA, Cerami A (1986). Structure of lysine adducts with 16-hydroxyestrone and Cortisol. J Steroid Biochem 25:127-133.
45. Jones ERH, Meakins GD, Miners JO, Wilkins AL (1975). Microbiological hydroxylation. Part XXI. Hydroxylations of 3-halogeno-17-oxo, 3-halogeno-7-oxo, and 17-halogeno-3-oxo-androstanes by the fungi Calonectria decora, Rhizopus nigricans, and Aspergillus ochniceus. J Chem Soc Perkin Trans 1 2308-2312.
46. Wawrzak Z, Duux WL, Strong PD. Weisz J (1988). Steroid structure and function: Molecular conformation of 4-hydroxyestradiol and its relation to other catechol estrogens. J Steroid Biochem 29:387-392.
47. Pfeiffer DG, MacLusky NJ, Barnea E, Naftolin F, Krey LC, Loriaux DL, Merriam GR (1986). Are catechol oestrogens obligatory mediators of oestrogen action in the central nervous system? I characterization of pharmacological probes with different receptor binding affinities and catechol oestrogen formation rates. J Endocrinol 110: 489-497.
48. Weisman RA, Sahakian JA. Brodack JW, Welch MJ, Merrill JC, Li AP, Katzenellenbogen JA (1991). The use of cultured liver cells from rats and humans to study the metabolism of the PET imaging agent (F-18)-fluoroestradiol. J Label Compound Radiopharm 31: 426.
49. Li PK, Pillai R, Dibbelt L (1995). Estrone sulfate analogs as estrone sulfatase inhibitors. Steroids 60:299-306.
50. Elger W, Schwarz S, Reddersen G, Schneider B (1996). Novel estrogens with reduced hormonal and metabolic first pass liver interactions. Exp Toxicol Pathol 48:345-346.